2Alastaur JM,Robert JP,John W. Malignant mesothehoma[J].Orphanet Journal of Rare Diseases,2008,3:34 -45.
3Vogelzang NJ ,Rusthoven JJ,Symanowski J ,et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma[J].J Clin Oncol, 2003,21 (14): 2636-2644.
2[3]Butchart EG,AshcroftT,Barnsley WC,et al.Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura.Thorax,1976,31:15
3[4]Curran D,Sahmoud T,Therasse P,et al.Prognostic factors in patients with pleural mesothelioma:The European Organisation for Research and Treatment of Cancer experience.J Clin Oncol,1998,16:145
4[5]Rusch VW,Venkatraman E.The importance of surgical staging in the treatment of malignant pleural mesothelioma.J Thorac Cardiovasc Surg,1996,111:815
5[7]The International Mesothelioma Interest Group.A proposed new international TNM staging system for malignant pleural mesothelioma.Chest,1995,108 (4):1122
7[9]Sugarbaker DJ,Flores RM,Jaklitsch MT,et al.Resection margins,extrapleural nodal status and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma:Results in 183 patients.J Thorac Cardiovasc Surg,1999,117:54
8[10]Sugarbaker DJ,Jaklitsch MT,Bueno R,et al.Prevention,early detection,and management of complications after 328 consecutive extrapleural pneumonectomies.J Thorac Cardiovasc Surg,2004,128:138
9[11]Shaw P,Agarwal R.Pleurodesis for malignant pleural effusions.Cochrane Database Syst Rev,2004.CD002916
10[12]Berghmans T,Paesmans M,Lalami Y,et al.Activity of chemotherapy and immunotherapy on malignant mesothelioma:A systematic review of the literature with meta-analysis.Lung Cancer,2002,38:111
